Prognostic value of endothelial microparticles in patients with heart failure. - Wikidata - awgldk - TriplyDB

Prognostic value of endothelial microparticles in patients with heart failure.

Prognostic value of endothelial microparticles in patients with heart failure.

http://www.wikidata.org/entity/Q39840829

about

Microvesicles as a potential biomarker of neoplastic diseases and their role in development and progression of neoplasm Novel methodologies for biomarker discovery in atherosclerosis Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles.Small-size circulating endothelial microparticles in coronary artery disease Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis.Increased carotid intima-media thickness and reduced distensibility in human class III obesity: independent and differential influences of adiposity and blood pressure on the vasculature.Circulating microparticles: square the circle.Extracellular Vesicle Proteins Associated with Systemic Vascular Events Correlate with Heart Failure: An Observational Study in a Dyspnoea Cohort.Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy.The Association of Subclinical Hypothyroidism and Pattern of Circulating Endothelial-Derived Microparticles Among Chronic Heart Failure Patients.Immuno-analysis of microparticles: probing at the limits of detection.Microvesicles as potential ovarian cancer biomarkers.Microvascular endothelial cells-derived microvesicles imply in ischemic stroke by modulating astrocyte and blood brain barrier function and cerebral blood flow.Microvesicles: potential markers and mediators of endothelial dysfunction.Endothelial microparticles: missing link in endothelial dysfunction?Extracellular vesicle profiling and their use as potential disease specific biomarker.Circulating cell-derived microparticles as biomarkers in cardiovascular disease.Endothelial microparticles act as novel diagnostic and therapeutic biomarkers of circulatory hypoxia-related diseases: a literature review.Isolation and Characterization of Microvesicles from Peripheral Blood.Circulating endothelial cell-derived extracellular vesicles mediate the acute phase response and sickness behaviour associated with CNS inflammation.Effect of abciximab on the levels of circulating microparticles in patients with acute myocardial infarction treated by primary angioplasty.High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders.Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases.Exosomes-Based Biomarkers for the Prognosis of Cardiovascular Diseases.Blood cell microparticles as biomarkers of hemostatic abnormalities in patients with implanted cardiac assist devices.Non-contact acoustic capture of microparticles from small plasma volumes.Circulating Microparticles Decrease After Cardiac Stress in Patients With Significant Coronary Artery Stenosis.Endothelial microparticles increase in mitral valve disease and impair mitral valve endothelial function.Arterial erectile dysfunction: reliability of new markers of endothelial dysfunction.Extracellular Vesicles: A Novel Target for Exercise-Mediated Reductions in Type 2 Diabetes and Cardiovascular Disease Risk

P2860

Q26768704-9B412842-DD9C-4BA0-9A04-25BF25BE6B59 Q28088373-17D81CDA-D81A-4689-B8D8-E013F798C827 Q34026858-7338C81D-7658-4174-B606-51480BE0B33D Q34035371-0BB315A0-432F-42F3-B4B6-4E075818FAFC Q34271108-E7E19164-9C14-4C88-8B9D-5EA62E2C092C Q34559005-C785EF72-6A46-4E2C-9D8A-AA68BAEDD4D9 Q34680832-5143E40D-0F1F-4204-9A70-2E7BE749C776 Q35907034-3600B2AA-EF75-48DD-A4FB-C12CBE91B688 Q35949057-F7F89A11-91DC-4BD5-8273-C481BD0DF025 Q36215909-0E8FCF1F-DD03-44C8-93D4-810BAAF35088 Q36265919-37625DDF-4DD7-43E0-A337-5EC015C952FB Q36635032-EE76CC24-8FC8-4B90-8EEE-1D38C83D4EB4 Q36980988-302F036A-4CA4-49E5-BC02-E862031A3857 Q37273154-9E9D395B-C2B3-45E2-A99D-01BC0E50108E Q38001993-FF9E8224-3A7C-45EC-938B-66D05490F9AE Q38250056-EC526A2B-248D-4586-A087-CD59A593E11A Q38944216-785013AF-1EB6-4445-ADD3-CD06710CE509 Q39186270-50ACC939-9379-4735-9E71-875801E27CB8 Q40360154-7D0F1F3D-7832-4250-9B23-B1C8E7DFF9FC Q41548432-B3CE7BC2-9497-4179-863C-54A68E262B07 Q41765654-12155967-25E8-4061-AED0-9346FBF2DF8F Q48987219-588301BD-5C3C-4FD3-B3FC-72DB89713885 Q49807920-0B87B5E7-6F13-42AF-84B9-19B5C84ADEED Q49942926-0F4FD4CF-C400-48DF-8682-F43E2EAF7D94 Q51159991-A899FE80-616B-455A-8C55-6931DFB0A2A0 Q51493562-9D2903C5-DF43-46E5-9832-D4095F539E6B Q51644749-5A6338B6-B0F6-4BE8-B30D-169A1737CC27 Q53121379-41AE8D1B-71DF-42F6-ABED-D3125AF0E2B5 Q53137736-B3D11DE3-9A73-4F3F-935E-9D802A56CA7F Q56358143-D463D122-1D36-46E3-9A8E-4C424B9F0570

P2860

Prognostic value of endothelial microparticles in patients with heart failure.

http://www.wikidata.org/entity/Q39840829

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Prognostic value of endothelial microparticles in patients with heart failure.

@en

Prognostic value of endothelial microparticles in patients with heart failure.

@nl

type

label

Prognostic value of endothelial microparticles in patients with heart failure.

@en

Prognostic value of endothelial microparticles in patients with heart failure.

@nl

prefLabel

Prognostic value of endothelial microparticles in patients with heart failure.

@en

Prognostic value of endothelial microparticles in patients with heart failure.

@nl

P1433

Q39840829-98104FB1-9DAA-488A-9457-7DEF4351C179

P1476

Q39840829-EF655117-1DA6-4279-BB01-20775FFDE46D

P2093

Q39840829-0A69288F-6A06-4E5D-AA28-FA75C5BB0C7E

Q39840829-0C5BACEA-8B31-45E5-9E94-12FA7D63ACDD

Q39840829-0DE99915-8712-4B60-B611-1A10BE1259C7

Q39840829-120AF46C-882A-4C19-8635-3F359B22F4E9

Q39840829-3B73A460-08D3-409D-8653-94C4753C8217

Q39840829-4D97B275-6E17-4995-B434-331385DE7FA9

Q39840829-5422F748-99E5-4837-BD6F-E3FC351F3534

Q39840829-5C14DED0-BDF1-4FCC-A0F5-322A4E9B5A32

Q39840829-5D488A6A-630B-40C2-860B-7B268F453ED0

Q39840829-8515CEAE-C014-4825-808E-784014ABB62B

P2860

Q39840829-03736BA1-82D5-489B-AD70-2A0DE1ABE52C

Q39840829-44D30E17-22EA-46DE-9E97-78C2D5526A61

Q39840829-457075AF-C5EC-4890-AD84-70B2190D5AC7

Q39840829-4B858FC1-145A-4206-A538-C183EEA49008

Q39840829-4E6AAF35-63F5-4A39-9727-DD5556B78BFF

Q39840829-646C4DF4-D35A-4ACF-9BA9-016234C61B19

Q39840829-76815C79-4C1A-4709-B957-A807A2D75525

Q39840829-7FA4CFF8-8781-4723-AD3B-D50F58F7BAB8

Q39840829-8E9A2F2E-4BAB-4ABD-90DE-44EFD596A70F

Q39840829-975BB3A1-E824-473E-A0B9-4A27054D0E7D

P304

Q39840829-339C2C4C-1190-493D-95F3-60318F7CE588

P31

Q39840829-EFDF3C3F-B3D5-47E5-8973-2FEC568ABCD4

P356

Q39840829-52EAF370-E2FD-438F-86D6-27539E957ABD

P433

Q39840829-8202D13B-023F-435B-84EF-E8F719C8550F

P478

Q39840829-623B277B-B500-439F-9584-E848A9614BB6

P577

Q39840829-300B25AC-71F9-481C-B26E-BE20AD299F2D

P5875

Q39840829-9076E88D-52F6-4622-AC8C-9F57FFA06F3E

P698

Q39840829-EAC6D082-0FDE-4DAA-80BF-742BD14D38A5

P921

Q39840829-818353D0-7042-4BBC-8C4D-0A43F972406B

Q39840829-A4E30DE3-C823-4DD0-8A51-A3ED6637CD4A

Q39840829-E59B54A7-A974-4045-B053-081FBB4F2D2F

P356

P1433

European Journal of Heart Failure

P1476

Prognostic value of endothelial microparticles in patients with heart failure.

@en

P2093

Eiichi Akiyama

http://www.w3.org/2001/XMLSchema#string

Hideaki Jinnouchi

http://www.w3.org/2001/XMLSchema#string

Hisao Ogawa

http://www.w3.org/2001/XMLSchema#string

Hitoshi Sumida

http://www.w3.org/2001/XMLSchema#string

Junichi Matsubara

http://www.w3.org/2001/XMLSchema#string

Keisuke Ohba

http://www.w3.org/2001/XMLSchema#string

Koichi Sugamura

http://www.w3.org/2001/XMLSchema#string

Kunihiko Matsui

http://www.w3.org/2001/XMLSchema#string

Masaaki Konishi

http://www.w3.org/2001/XMLSchema#string

Seigo Sugiyama

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarkers in heart failure

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Microparticles in cardiovascular diseases.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the

Clinical utility of endothelial function testing: ready for prime time?

Circulating markers of endothelial function in cardiovascular disease.

Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease.

Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.

Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods.

Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.

P304

1223-1228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURJHF/HFQ145

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46149058

http://www.w3.org/2001/XMLSchema#string

P698

20817695

http://www.w3.org/2001/XMLSchema#string

P921